- Home
- CTNT vs VIVS Comparison
CTNT vs VIVS Comparison
Compare CTNT & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNT | VIVS |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.8M |
| IPO Year | 2023 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CTNT | VIVS |
|---|---|---|
| Price | $0.24 | $0.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 745.2K | 619.2K |
| Earning Date | 05-08-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.74 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,288,536.00 | ★ $4,603,000.00 |
| Revenue This Year | $42.49 | $42.38 |
| Revenue Next Year | $22.22 | $15.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 182.69 | 8.82 |
| 52 Week Low | $0.02 | $0.26 |
| 52 Week High | $4.21 | $4.98 |
Technical Indicators
Market Signals| Indicator | CTNT | VIVS |
|---|---|---|
| Relative Strength Index (RSI) | 17.69 | 37.18 |
| Support Level | $0.02 | $0.27 |
| Resistance Level | $1.55 | $0.58 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 0.00 | 59.55 |
Price Performance
Historical ComparisonAbout CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.
About VIVS VivoSim Labs Inc.
VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.